Cargando…

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016

Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) assessed antiviral susceptibility of 14,330 influenza A and B viruses collected by WHO-recognized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gubareva, Larisa V., Besselaar, Terry G., Daniels, Rod S., Fry, Alicia, Gregory, Vicki, Huang, Weijuan, Hurt, Aeron C., Jorquera, Patricia A., Lackenby, Angie, Leang, Sook-Kwan, Lo, Janice, Pereyaslov, Dmitriy, Rebelo-de-Andrade, Helena, Siqueira, Marilda M., Takashita, Emi, Odagiri, Takato, Wang, Dayan, Zhang, Wenqing, Meijer, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667636/ https://www.ncbi.nlm.nih.gov/pubmed/28802866 http://dx.doi.org/10.1016/j.antiviral.2017.08.004

Ejemplares similares

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
por: Govorkova, Elena A., et al.
Publicado: (2022)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan
por: Takashita, Emi, et al.
Publicado: (2013)

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
por: Sleeman, Katrina, et al.
Publicado: (2011)

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
por: Takashita, Emi, et al.
Publicado: (2020)

Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
por: Moss, Robert, et al.
Publicado: (2016)

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
por: Brookes, Daniel W., et al.
Publicado: (2011)

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution
por: Farrukee, Rubaiyea, et al.
Publicado: (2022)

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
por: Takashita, Emi, et al.
Publicado: (2018)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil
por: Nakauchi, Mina, et al.
Publicado: (2020)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
por: Ito, Hiroko, et al.
Publicado: (2020)

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses
por: Hurt, Aeron C., et al.
Publicado: (2012)

Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity
por: Silva, Thauane, et al.
Publicado: (2018)

Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza
por: Mawatari, Momoko, et al.
Publicado: (2019)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
por: Hurt, Aeron C., et al.
Publicado: (2013)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts
por: Tang, Jing, et al.
Publicado: (2019)

Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility
por: Farrukee, R., et al.
Publicado: (2018)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
por: Ujike, Makoto, et al.
Publicado: (2011)

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
por: Takashita, Emi, et al.
Publicado: (2019)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015)

Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice
por: Tang, Jing, et al.
Publicado: (2021)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49d9srmoo6c020lfqfnm52jh6d